08:21 AM EDT, 10/09/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that it has completed its acquisition of V-Wave, which develops treatment options for patients with heart failure.

The company said V-Wave will be folded into its MedTech unit.

The deal will be accounted for as an asset acquisition, which will result in a charge of about $600 million in Q4, the company said, adding that it expects the acquisition to dilute adjusted EPS by about $0.24 in 2024 and about $0.06 in 2025.

Price: 160.89, Change: +1.20, Percent Change: +0.75